Trial Profile
Phase Ib trial investigating the pharmacokinetics, tolerability and bioavailability of an orally ingestible, soft gel insulin capsule [ORMD 0801] in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2010
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Oramed Pharmaceuticals
- 24 Jan 2008 New trial record.